Which criteria should be analyzed to assess opportunities in biobanks and biological samples?
Sectorious reports on biobanks and biological samples analyze collection, storage, annotation, sample quality, consent, traceability, access to linked clinical data, preservation infrastructure, hospital partnerships and business models. They help laboratories, biotech firms, hospitals, investors and translational research programs identify the most valuable collections, secure compliance and compare opportunities linked to qualified biological data.